Entity Common Stock, Shares Outstanding of GlobeStar Therapeutics Corp from 30 Jun 2011 to 04 Oct 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
GlobeStar Therapeutics Corp quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Jun 2011 to 04 Oct 2024.
  • GlobeStar Therapeutics Corp Entity Common Stock, Shares Outstanding for the quarter ending 04 Oct 2024 was 1,241,105,695.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

GlobeStar Therapeutics Corp Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 1,241,105,695 04 Oct 2024 10-Q 11 Oct 2024 2024 Q3
Q2 2024 1,241,105,695 +453,417,425 +58% 21 Jun 2024 10-Q 28 Jun 2024 2024 Q2
Q1 2024 1,162,921,101 11 Mar 2024 10-Q 12 Mar 2024 2024 Q1
Q4 2023 1,026,417,320 +256,056,704 +33% 16 Jan 2024 10-K 19 Jan 2024 2023 FY
Q2 2023 787,688,270 +144,775,488 +23% 25 May 2023 10-Q 31 May 2023 2023 Q2
Q4 2022 770,360,616 +169,985,790 +28% 03 Jan 2023 10-K 09 Jan 2023 2022 FY
Q3 2022 693,996,935 +147,501,209 +27% 22 Aug 2022 10-Q/A 23 Aug 2022 2022 Q3
Q2 2022 642,912,782 +167,274,007 +35% 23 May 2022 10-Q 01 Jun 2022 2022 Q2
Q4 2021 600,374,826 +134,000,712 +29% 27 Dec 2021 10-K 05 Jan 2022 2021 FY
Q3 2021 546,495,726 20 Aug 2021 10-Q 23 Aug 2021 2021 Q3
Q2 2021 475,638,775 +92,518,615 +24% 20 May 2021 10-Q 21 May 2021 2021 Q2
Q4 2020 466,374,114 +256,073,082 +122% 26 Jan 2021 10-Q 28 Jan 2021 2021 Q1
Q2 2020 383,120,160 +254,316,185 +197% 14 Jul 2020 10-Q 14 Jul 2020 2020 Q3
Q1 2020 319,439,508 +212,976,797 +200% 04 May 2020 10-Q 05 May 2020 2020 Q2
Q4 2019 210,301,032 +125,212,179 +147% 30 Dec 2019 10-K 31 Dec 2019 2019 FY
Q2 2019 128,803,975 +65,800,379 +104% 26 Jul 2019 10-Q 02 Aug 2019 2019 Q3
Q1 2019 106,462,711 14 May 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 85,088,853 +39,004,786 +85% 31 Dec 2018 10-K 03 Jan 2019 2018 FY
Q2 2018 63,003,596 +21,919,529 +53% 31 Jul 2018 10-Q 01 Aug 2018 2018 Q3
Q4 2017 46,084,067 10 Jan 2018 10-K 16 Jan 2018 2017 FY
Q3 2017 41,084,067 +9,563,400 +30% 18 Aug 2017 10-Q/A 23 Aug 2017 2017 Q3
Q2 2017 41,084,067 +31,061,524 +310% 19 May 2017 10-Q 19 May 2017 2017 Q2
Q1 2017 38,784,067 +28,881,524 +292% 28 Mar 2017 10-K 29 Mar 2017 2016 FY
Q3 2016 31,520,667 13 Sep 2016 10-Q/A 16 Sep 2016 2016 Q3
Q2 2016 10,022,543 +2,388,126 +31% 17 May 2016 10-Q/A 16 Jun 2016 2016 Q2
Q1 2016 9,902,543 -25,417,594 -72% 16 Feb 2016 10-Q 22 Feb 2016 2016 Q1
Q4 2015 9,738,543 -18,281,594 -65% 11 Jan 2016 10-K/A 22 Jan 2016 2015 FY
Q2 2015 7,634,417 -14,125,609 -65% 13 Aug 2015 10-Q/A 24 Sep 2015 2015 Q3
Q1 2015 35,320,137 +19,206,407 +119% 15 May 2015 10-Q/A 17 Sep 2015 2015 Q2
Q4 2014 28,020,137 +16,156,407 +136% 12 Jan 2015 10-K/A 27 Jan 2015 2014 FY
Q2 2014 21,760,026 +12,496,296 +135% 12 Aug 2014 10-Q/A 04 Sep 2014 2014 Q3
Q1 2014 16,113,730 +6,850,000 +74% 15 May 2014 10-Q 20 May 2014 2014 Q2
Q4 2013 11,863,730 +5,367,315 +83% 09 Jan 2014 10-K/A 23 Jan 2014 2013 FY
Q2 2013 9,263,730 -4,436,270 -32% 31 Jul 2013 10-Q 14 Aug 2013 2013 Q3
Q1 2013 9,263,730 14 May 2013 10-Q/A 16 May 2013 2013 Q2
Q4 2012 6,496,415 -5,503,585 -46% 09 Jan 2013 10-K/A 07 Mar 2013 2012 FY
Q2 2012 13,700,000 +1,700,000 +14% 31 Jul 2012 10-Q/A 20 Sep 2012 2012 Q3
Q4 2011 12,000,000 22 Dec 2011 10-K 29 Dec 2011 2011 FY
Q2 2011 12,000,000 30 Jun 2011 10-Q 11 Aug 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.